Vaccines and Preventable Diseases:

PCV and PPSV Vaccine Articles

Related articles

2012 Articles

• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  Source: MMWR, October 12, 2012, Vol. 61(40):816-819.
• Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
  Source: MMWR, June 1, 2012, Vol. 61(21):394-5.
• Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period
  Authors: De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, et al.
  Source: Vaccine. Epub ahead of print. May 2012.

2011 Articles

• Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months -- Selected U.S. Regions, 2010-2011
  Authors: CDC
  Source: MMWR. 2011;60(43)1477-81.
• Healthcare utilization and cost of pneumococcal disease in the United States
  Authors: Huang SS, Johnson KM, Ray GT, et al.
  Source: Vaccine. Epub ahead of print. April 2011.

 

2010 Articles

• Prevention of Pneumococcal Disease Among Infants and Children -- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
  Source: MMWR, December 10, 2010, Vol. 59(RR11):1-18

 

2009 Articles

• Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
  Authors: Hsu HE, Shutt KA, Moore MR, et al.
  Source: N Engl J Med, 2009, Vol. 360(3):244-256
• The controversy over the efficacy of pneumococcal vaccine
  Authors: Andrews R, Moberley SA
  Source: Can. Med. Assoc. J. 2009, Vol. 180:18-19
• Efficacy of pneumococcal vaccination in adults: a meta-analysis
  Authors: Huss A, Scott P, Stuck AE, et al.
  Source: Can. Med. Assoc. J 2009, Vol. 180(1):48-58

2008 Articles

• Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
  Authors: Jackson LA, Janoff EN
  Source: Clin Infect Dis, November 15, 2008, Vol. 47(10):1328-38
• Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine on Pneumonia in HIV-Infected Adults in the United States, 1998—2003
  Authors: Teshale EH, Hanson D, Flannery B, Phares C, Wolfe M, Schuchat A, Sullivan P
  Source: Vaccine, October 29, 2008, Vol. 26(46):5830-4
• Progress in Introduction of Pneumococcal Conjugate Vaccine -- Worldwide, 2000-2008
  Source: MMWR, October 24, 2008, Vol. 57(42):1148-1151
• 23-Valent Pneumococcal Polysaccharide Vaccine: WHO Position Paper [PDF - 308KB / 12 pages]
  Authors: World Health Organization
  Source: WER, October 17, 2008, Vol. 83(42):373-84
• Influenza and Pneumococcal Vaccination Rates among Vietnamese, Asian, and Non-Hispanic White Americans
  Authors: Daniels NA, Gildengorin G, Nguyen TT, Liao Y, Luong TN, McPhee SJ
  Source: J Immigr Minor Health, October 7, 2008
• Initial and Subsequent Response to Pneumococcal Polysaccharide and Protein-Conjugate Vaccines Administered Sequentially to Adults Who Have Recovered from Pneumococcal Pneumonia
  Authors: Musher DM, Rueda AM, Nahm MH, Graviss EA, Rodriguez-Barradas MC
  Source: J Infect Dis, October 1, 2008, Vol. 198(7):1019-27
• Barriers to Adult Immunization
  Authors: Johnson DR, Nichol KL, Lipczynski K
  Source: Am J Med, July 2008, Vol. 121(7 Suppl 2):S28-35
• Percentage of Adults Aged >65 Years Who Ever Received a Pneumococcal Vaccination, by Sex, Age Group, and Race/Ethnicity -- National Health Interview Survey, United States, 2007
  Source: MMWR, July 4, 2008, Vol. 57(26):723
• Status of Influenza and Pneumococcal Vaccination among Older American Indians and Alaska Natives
  Authors: Lindley MC, Groom AV, Wortley PM, Euler GL
  Source: Am J Public Health, May 2008, Vol. 98(5):932-8
• Economic Evaluation of Standing Order Programs for Pneumococcal Vaccination of Hospitalized Elderly Patients
  Authors: Middleton DB, Lin CJ, Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS, Fox DE
  Source: Infect Control Hosp Epidemiol, May 2008, Vol. 29(5):385-94
• Status of Influenza and Pneumococcal Vaccination among Older American Indians and Alaska Natives
  Authors: Lindley MC, Groom AV, Wortley PM, Euler GL
  Source: Am J Public Health, May 2008, Vol. 98(5):932-8
• Invasive Pneumococcal Disease among White Mountain Apache Adults, 1991-2005
  Authors: Bliss SJ, Larzalere-Hinton F, Lacapa R
  Source: Arch Intern Med, April 14, 2008, Vol. 168(7):749-55
• Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated
  Source: MMWR, April 4, 2008, Vol. 57(13):343-344
• Patient Views on Reminder Letters for Influenza Vaccinations in an Older Primary Care Patient
  Population: A Mixed Methods Study
  Authors: Anderson KK, Sebaldt RJ, Lohfeld L, et al.
  Source: Can J Public Health, March-April 2008, Vol. 99(2):133-6
• Alternative Strategies for Adult Pneumococcal Polysaccharide Vaccination: A Cost-Effectiveness Analysis
  Authors: Smith KJ, Zimmerman RK, Lin CJ, Nowalk MP, Ko FS, McEllistrem MC, Roberts MS
  Source: Vaccine, March 10, 2008, Vol. 26(11):1420-31
• Cost of Vaccinating Refugees Overseas Versus After Arrival in the United States, 2005
  Source: MMWR, March 7, 2008, Vol. 57(09):229-232
• Revaccination of Adults with Spinal Cord Injury Using the 23-Valent Pneumococcal Polysaccharide Vaccine
  Authors: Waites KB, Canupp KC, Chen YY, DeVivo MJ, Nahm MH
  Source: J Spinal Cord Med, 2008, Vol. 31(1):53-9

2007 Articles

• The 23-Valent Pneumococcal Polysaccharide Vaccine Does Not Provide Additional Serotype Antibody Protection in Children Who Have Been Primed with Two Doses of Heptavalent Pneumococcal Conjugate Vaccine
  Authors: Balmer P, Borrow R, Arkwright PD
  Source: Vaccine, August 21, 2007; 25(34):6321-6325
• The Association between Pneumococcal Pneumonia and Acute Cardiac Events
  Authors: Musher DM, Rueda AM, Kaka AS, Mapara SM
  Source: Clin Infect Dis, July 15, 2007; 45(2):158-165
• Comparative Reactogenicity and Immunogenicity of 23-Valent Pneumococcal Vaccine Administered by Intramuscular or Subcutaneous Injection in Elderly Adults
  Authors: Cook IF, Pond D, Hartel G
  Source: Vaccine, June 15, 2007; 25(25):4767-4774
• Invasive Pneumococcal Disease Epidemiology and Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine in Alaska Native Adults
  Authors: Singleton RJ, Butler JC, Bulkow LR, et al
  Source: Vaccine, March 7, 2007; 25(12):2288-2295

2006-1998 articles on pneumococcal vaccines

 Return to main Pneumococcal Vaccination page

• Email this page
• Printer-friendly version

• Help
• Glossary / Acronyms
• Site Map